Jump directly to content

PFAROS: Minimize the presence of PFAS in healthcare

PFAROS
Laboratory work

PFAROS is a 5-year project that will provide concrete tools and solutions to support a safer, greener, and more resilient healthcare system for Europe.

To lead efforts to develop and evaluate alternatives to PFAS in pharmaceutical manufacturing, and to map and identify areas of use and types of PFAS within the healthcare sector.
Active
Life Science
Not applicable
5 years
41 M Euro
Division: Division Life Science

PFAROS is a European initiative aimed at accelerating the transition away from PFAS substances in the pharmaceutical and medical device industries. In line with the EU’s public health, environmental, and industrial policy objectives, PFAROS is developing safe, scalable, and regulatory-compliant alternatives, ensuring that innovation in healthcare goes hand in hand with sustainability.

PFAROS’s mission is to replace PFAS in medical and pharmaceutical applications through an interdisciplinary approach that combines validated alternatives, advanced degradation and waste management technologies, and data science to support well-informed replacement measures and policy initiatives.

At the heart of PFAROS is a policy-based, AI-driven data tool that maps the use of PFAS, identifies viable alternatives, and integrates data on life cycle, exposure, and toxicology—enabling evidence-based policy and regulatory decisions. Combined with broad stakeholder engagement and the integration of social sciences, the project ensures a fair and well-informed transition away from PFAS.

PFAROS will ultimately pave the way for a PFAS-free future for Europe’s healthcare systems by:

   - Develop an integrated testing and evaluation framework to implement the SSbD method for PFAS replacement;

   - Provide validated, industry-ready PFAS alternatives to ensure rapid adoption;

   - Enable data-driven decision-making through an AI-powered PFAROS data tool tailored to support the needs of government agencies;

 - Ensure widespread adoption and promote cross-sectoral collaboration with industry, regulatory authorities, academia, and civil society;

   - Position the EU as a global leader in sustainable chemicals policy and innovation in healthcare.

RISE is one of the major technical partners, leading activities in materials characterisation, pharmaceutical process development, PFAS analytics, SSbD implementation, peptide synthesis, and exploitation. RISE also coordinates several validation and industrial uptake activities across the project.

RISE contribution in detail:

  • leads the evaluation, comparison, and implementation of Safe and Sustainable by Design (SSbD) approaches for PFAS replacement in healthcare (William Mackintosh) 
  • contributes to mapping PFAS use in healthcare by identifying PFAS-containing products, their functions, and potential alternatives. RISE supports the development of digital substitution tools and integrates technical, safety, sustainability, and exposure data into the project's semantic platform to enable informed decision-making (Lisa Skedung)
  • leads the characterisation and benchmarking of existing PFAS-containing materials and newly developed PFAS-free alternatives (Ulla Elofsson)
  • leads investigations into interactions between PFAS-free materials and pharmaceutical ingredients, proteins, nucleic acids, blood components, and tissues (Ulla Elofsson)
  • develops modelling and experimental approaches to understand and minimise interactions between pharmaceutical products and PFAS-free contact materials (Ulla Elofsson)
  • leads the development of PFAS-free peptide synthesis, purification, and analytical methodologies as well as validation and scale-up. The work focuses on replacing TFA and establishing scalable industrial processes guided by Safe and Sustainable by Design principles. (Dana Michel & Tomasz Janosik)
  • leads the development of analytical methods to identify and quantify PFAS and PFAS alternatives in healthcare products and exposure scenarios, generating data for risk assessment, safety evaluation, and regulatory compliance (Lisa Skedung)
  • provides in silico modelling and predictive tools to evaluate polymer compatibility and optimize PFAS-free material formulations (Petru Niga)
  • contributes machine learning and data-driven optimisation tools to support the development of PFAS-free coatings (Petru Niga) 
  • will explore PFAS removal using supercritical CO₂ extraction, optimising for separation efficiency and material circularity (Petru Niga)

This project is supported by the Innovative Health Initiative (IHI JU) consortium under grant agreement No. 101251281. The consortium receives support from the European Union’s Horizon Europe research and innovation program and from COCIR, EFPIA, Europa Bío, MedTech Europe, and Vaccines Europe.

 

Karin Persson

Teknisk Doktor
+46 10 516 60 72 Read more about Karin
Profile image

Contact Karin

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
Profile image

Contact Lisa

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
3. Good health and well-being
Projekt logo: PFAROS Logo Project end date: Health and life science Sekundär områdes navigation: Chemical and biological analysis

Acoustic Properties of Medical Devices

Name of service (page headline, shown in promos – maximum of 70 characters incl. spaces): Acoustic Properties of Medical Devices Lead (include SEO-words and the main benefits for your target groups. Stick to one paragraph, maximum 2-3 sentences):

We offer testing and evaluation of the acoustic properties of medical devices. Our measurements and analyses provide a basis for assessing whether the sounds are appropriate for the product’s function and intended use environment, and whether they may pose a risk of disturbance or burden.

Purpose/Benefit:

Sound from medical devices and equipment affects patient safety, the work environment, and the user experience in healthcare and care settings. Functional sounds, such as alarms and monitoring signals, are intended to convey information and support patient safety. 

These sounds can negatively affect:

  • the patient’s sense of security and comfort,
  • healthcare staff’s concentration, communication, and fatigue levels.

In addition, the overall acoustic environment is influenced by background noise from, for example, fans, medical pumps, and other technical equipment, which is often perceived as disturbing.

At RISE, we support you in ensuring that sound from medical devices contributes to patient safety, a good working environment, and better user experience. Through our measurements and assessments for clinical and care-near environments, you receive a basis for developing both the product’s function and the overall acoustic environment in healthcare.

In our acoustic laboratory, we carry out independent testing and measurements of medical devices, and we also perform measurements and assessments in real clinical and care-near environments to provide you with a complete picture of the acoustic environment.

In addition to objective measurements, we can conduct listening tests and user-centered evaluations to assess how sound is perceived and how it affects healthcare staff and patients – giving you a basis for developing safer and more user-friendly products as part of risk management, usability, and product development.

Method (what/which methods are used to perform the service):

We measure and evaluate according to established methods and standards for sound, vibration, usability, and safety. The method is adapted to the product’s intended use, risk profile, and regulatory context – from early product development to verification, risk assessment, and documentation prior to certification or market access.

Depending on the question at hand, the work may include
•    measurement of the product’s sound power level, sound pressure level at the patient or caregiver position, and vibration emission
•    evaluation of alarm signals’ audibility and suitability for the intended environment
•    verification of sirens and alarm devices against applicable regulatory requirements.

Where relevant, we use established measurement methods, standards, and regulations, for example ISO 11201, ISO 3744, ISO 24501, EN 1789, relevant parts of the IEC/EN 60601 series, and VVFS 2003:29.
Measurements can be carried out both in a controlled laboratory environment and in real-use settings, such as ambulances, incubators, or other care-near environments. In this way, the results can be adapted to the product’s actual use and provide a relevant basis for product development, verification, risk assessment, or documentation.
The goal is to ensure that the products support a safe and appropriate sound environment, without unnecessarily burdening patients, staff, or users.

Delivery (what does the client get after performed service – e.g. a report, certificate etc.):

Our standard deliverable is test reports (in Swedish and/or English), tailored to regulatory and technical needs. If required, we can also provide statements, assessments, or supporting technical documentation and certification processes, depending on the scope of the assignment and the agreement.

We can also provide supporting material for CE marking under the MDR, as well as technical documentation and risk and usability analyses where sound and acoustic aspects are included.

Area:
Work environment
Construction
Medical devices
Perception
Testing
Contact person (Enter one name per field. Activated personal contact pages will appear automatically):
Nata Amiryarahmadi, Senior Forskare
Pontus Gräsberg, Laboratorieingenjör
Acoustic Properties of Medical Devices
Field measurements: Yes Price type: 1 Division: Do not use - Division Built Environment Preparation: No preparation required Standards:

ISO 11201, ISO 3744, ISO 24501, EN 1789, IEC/EN 60601-serien, VVFS 2003:29 mm

Certification and marking: Product certification Type of service: Testing / Analysis / Evaluation Instrument: Acoustic measurement equipment General area: Sound and vibrations Delivery level:
Accredited
Non-accredited
nata.amir@ri.se,pontus.grasberg@ri.se
/en/about-rise/operations/mission-governance/policy-documents/privacy-policy
3. Good health and well-being
11. Sustainable cities and communities
Purpose - Header: Purpose Metod - Header: Method Delivery - Header: Deliverables More information - Header: Mer information
Request for quote
form
Construction Sekundär områdes navigation: Health and life science Tjänstetyp tagg:
Provning
Verifiering och validering

ReSCALE – Reasoning Agents for Sustainable Chemical Assessment

ReScale
Reasoning agent structured workflow

ReSCALE develops AI-based reasoning agents to support chemical safety, life-cycle assessment, and sustainable substitution in line with Safe and Sustainable by Design (SSbD). By integrating data, predictive models, and scientific knowledge, the project enables experts to make faster, more transparent decisions.

Deltagare
Active
Artificial intelligence Formulated products Risk and safety
Region Stockholm
1,5 år
3 120 500 kr
Division: Division Life Science

Challenge: complex decisions for chemical safety and sustainability

The development and use of chemicals place increasing demands on minimizing risks to human health and the environment. At the same time, current decision-making processes are often fragmented, where data from chemical databases, predictive models, and life cycle assessment (LCA) must be analyzed manually and separately. This makes it difficult for companies and authorities to quickly identify safer and more sustainable alternatives, especially in the context of substitution and the implementation of Safe and Sustainable by Design (SSbD).

Solution: AI-based reasoning agents for chemical assessment

Within ReSCALE, a new type of digital decision support is developed based on AI and so-called reasoning agents. These act as an “AI co-scientist” that can plan analyses, retrieve and integrate data from multiple sources, and synthesize and interpret results. By combining chemical databases, predictive models such as QSAR and toxicity models, scientific literature, and sustainability data, a more holistic and efficient chemical assessment becomes possible.

Customer value: better and faster decision-making

For industry and other stakeholders, this means that complex assessments can be performed faster, more systematically, and with greater transparency. The system supports the identification of safer and more sustainable alternatives, for example in solvent substitution, and enables trade-offs between functionality, safety, and environmental impact. This contributes to reduced risks, shorter development times, and stronger support for innovation and regulatory decision-making.

Pilot and application: focus on solvent substitution

The project includes a concrete pilot case where the technology is applied to solvent substitution – a priority area in industry. Existing tools and databases are integrated to demonstrate how AI-based reasoning agents can support experts in identifying and evaluating alternative chemicals that meet both performance and sustainability requirements.

Contribution to sustainable development and SSbD

ReSCALE contributes to the transition towards more sustainable and circular use of chemicals by operationalizing the principles of Safe and Sustainable by Design. By integrating safety, functionality, and life-cycle perspectives early in the development process, the project supports the creation of next-generation chemicals, materials, and processes that are safer for both people and the environment.

Profile image

Contact Petru

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
Project end date: Bildtext: Reasoning agent structured workflow Drug development Sekundär områdes navigation: Health and life science

VäXR: Learning mathematics with the support of virtual reality

VäXR
Man with VR glasses and hand controls

Could the difference between knowing and understanding lie in the experience itself? VäXR combines research in mathematics didactics with virtual reality to study effects on student learning and engagement.

Project manager
Active
Professional education
Not applicable
Three years
Division: Division Digital Systems and Societal Transformation

VäXR is a research-driven development project that is breaking new ground for Swedish schools. Many students struggle with abstract mathematical concepts, while research shows that experiential learning can be key to strengthening both engagement and understanding. By combining mathematics didactic research and VR and placing it in real teaching practice, VäXR explores how immersive learning environments can strengthen students' engagement, understanding and knowledge development.

The project is carried out in close collaboration between teachers, students, VR developers and researchers. This means that every part is rooted in educational research and the conditions that prevail in the school. The VR environment is continuously tested by students and teachers and further developed based on their feedback.

In an immersive VR environment, you can do things that neither a paper textbook nor a flat screen can offer. For example, you can stand on top of a huge pyramid and discover how angles and areas change when the shape is scaled up or down. Mathematics becomes something you feel in your body. In the VäXR application, which is being developed within the framework of the project, students are given the opportunity for an immersive learning experience where communication and exploration are at the center.

The project is also being researched by Stockholm University to study the effect of VR support on student learning. When the project reaches results, both the research study and methodological support will be published here.

VäXR is attracting interest and has, in addition to the press mentioned here, also been presented to the Riksdag. In parallel with VäXR, a project is underway within the framework of RISE EdTechLab in 2025-2026 where we explore how AI avatars can support learning in a VR environment, in a Swedish school context.

VäXR welcomes new school principals to join. Contact Sandra Wissting if you want to know more.

Sandra Wissting

Read more about Sandra
Profile image

Contact Sandra

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
4. Quality education
12. Responsible consumption and production
Kungsbacka kommun Montessori Mondial Region Västmanland Flens kommun Göteborgs stad Stockholms universitet Modda Sörmland
Projekt logo: VäXR logotyp Project end date: Lifelong learning Sekundär områdes navigation:
Health and life science
Advanced electronics

Brain Research Can Transform the Way We Build Cities

A new pilot project will show how brain research can contribute to creating cities that support public health. By integrating knowledge about the brain into urban planning, researchers aim to develop environments that reduce stress and enhance wellbeing. Fridhemsplan in Stockholm, Sweden, is the first living laboratory — with the goal of providing urban planners with scientific support to design urban environments that promote health. 

Future quantum threats require today’s decisions in healthcare

Quantum-secure healthcare

The Swedish healthcare sector is facing a technological shift that could change the rules of the game for information security. Quantum computers, which in the future may be able to crack today’s encryption, pose a long-term threat to the protection of sensitive data, such as health data.

At the same time, quantum technology opens the door to groundbreaking medical research and drug development. It is not a question of if the technology will arrive, but when. It is also a complex issue of how to manage the balance between innovation and security. What is clear, however, is that leaders within Sweden’s healthcare sector need to act now, before the threat becomes a reality.

A new report from RISE in collaboration with the Swedish E-health Agency, funded by Vinnova, states that time is short. The strategy hackers are already using is called "harvest now, decrypt later," which involves collecting encrypted data today to decrypt it once quantum computers become powerful enough. The decrypted information can then be used for purposes such as blackmail. For health data, which retains its value throughout an individual’s lifetime, this could be an existential threat.

"The greatest threat is not technical uncertainty but passivity, and decision-makers need to become aware of this. There are no finalized standards yet, but there are basic standards for post-quantum cryptography, PQC, which means the work can begin, and it needs to be done now. If we wait to start until everything is in place, we risk falling several years behind," says Michael Popoff, senior researcher in quantum technologies at RISE.

The report points out that crucial decisions need to be made now, ahead of new procurements and within management teams. The framework agreements signed during 2026 will determine whether systems are equipped with PQC by 2030, when the EU requires them to be. PQC consists of classical, non-quantum-based algorithms designed to withstand attacks from quantum computers. In other words, requirements for PQC readiness must be introduced immediately.

"We are seeing a development where security requirements are taking an increasingly prominent place in public procurement. This gives public actors a strategic opportunity to steer the market," says Åse Lundh Gravenius, senior researcher and legal expert.

She emphasizes that it may be necessary to have the ability to exclude suppliers for security reasons. But the issue is not just technical; it is also organizational and ethical. Quantum resilience must be anchored at the management level and integrated into risk management.

"The solutions are there, the technology is there, so let’s talk about it. This is not an IT issue, but a management issue. Health data are stories of people's lives, collected under trust. Protecting them is not just a legal obligation but also a social responsibility," says Michael Popoff.

The report suggests that Sweden quickly develops a technical reference document for quantum resilience within the healthcare sector before international standards are in place. Economic incentives, such as time-limited support for inventories and migration plans, can give municipalities and regions the capacity to act. Knowledge management and communication are crucial to awakening the will to act.

"We must see the synergies. There are clear overlaps between the measures required for quantum resilience and the processes now following from NIS2 and EHDS. It’s not about new resources, but about smart coordination and a high pace," says Åse Lundh Gravenius.

The message is clear: the threat is in the future, but the time to act is now. The path toward quantum resilience today is about using existing steering instruments strategically, such as procurement, executive management, and coordination with other regulations.

In a newly started Vinnova project led by RISE, researchers will now investigate how to implement the transition to quantum-secure solutions for health data. The project works with case studies and in working groups representing different actors in the ecosystem. The idea is to prepare actors handling health data, both private and public, for the migration to quantum-secure IT systems that will be required. The project concludes at the end of 2028, and the goal is then to have a secured transition to quantum-secure solutions for the healthcare sector by 2030.

Read the full report (pdf, in Swedish) Framtidens hot, dagens beslut - policy för kvantsäkra hälsodata

Michael Popoff

Senior Forskare
+46 10 228 41 33 Read more about Michael
Profile image

Contact Michael

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.

Åse Lundh Gravenius

Senior forskare/Rättslig expert
+46 10 228 41 56 Read more about Åse
Profile image

Contact Åse

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
Quantum technologies Sekundär områdes navigation: Health and life science

Climate Initiative for Swedish Health Care and Life Science sector

Shared climate initiative
Signing at the launch event in Stockholm

The National Climate Initiative is a public-private partnership within the Swedish healthcare and life science sector, initiated to accelerate the green transition. It brings together actors who want to contribute to sustainable development of the sector and is open to more organizations that want to be part of this joint effort.

Independent coordinator
Active
Not applicable
Ongoing
-
Division: Do not use - Division Built Environment

The participants in the initiative have high ambitions for climate change and are actively working throughout the value chain. The participants are part of each other's value chains and see collaboration as key for Sweden to achieve net-zero emissions by 2045. There is a clear need to accelerate the transition to sustainable healthcare in Sweden, in line with developments in other countries.

The shared climate ambition:

The shared climate ambition below will be signed by the participants in the national climate initiative at its launch on February 3, 2026. 

Together, within the Swedish healthcare and life science sector, we show the way towards a sustainable future

We commit to working together to reduce greenhouse gas emissions with the ambition to reach netzero by 2045 throughout the value chain. To achieve the ambition, everyone reduces their ownemissions through timed transition plans in line with the Paris Agreement. Each of us activelycontributes. Together, we build resilient, fair and resource-efficient care.  
​
Through preventive measures, early detection of diseases and effective treatment, we reduce the need for resource-intensive and climate-impacting care. We combine this with innovations, circular business models and material flows. Through transparency in the collaboration, we ensure that we follow up and continuously reduce climate impact. 
​
Under our clear national leadership, we embrace this ambition and strengthen Sweden's competitiveness.We show that a climate-neutral healthcare and life science sector is achievable – while safeguarding patient safety, public health and human rights.

The climate initiative enables joint projects and collaboration

Through the collaboration enabled by the national climate initiative for the healthcare sector, the actors plan to run joint projects in areas such as the circular economy and preventive care. Since the actors are forming each other's value chains, the collaboration will enable the actors to achieve much more than each organization could on its own.

Background

Societal transformation is underway in several areas to strengthen society's ability to meet the global climate and health crisis and thereby increase our resilience. This is also highlighted in the Swedish Life Science Strategy under goal 8.4, which emphasizes the need for increased efforts for climate change mitigation, climate adaptation, and reduced environmental impact. Many actors in the health and medical care sector have set their own goals but see a need for closer collaboration to achieve more.

The geopolitical situation and the need to build a resilient population and society have never been greater, and a major overhaul is underway within the EU. At the same time, the climate crisis is the greatest long-term challenge facing humanity, with clear links between climate change and deteriorating public health. The healthcare sector plays a crucial role in society, but at the same time accounts for around five per cent of global greenhouse gas emissions.

Against this background, collaboration across organizational and sectoral boundaries is essential. By bringing together actors along the entire value chain, the conditions are created for a joint contribution to the transition to more sustainable healthcare.

Why participate?

The Climate Initiative brings together actors who want to actively contribute to the green transition in healthcare and life sciences. By participating in the initiative, organizations become part of a national context where collaboration, common direction, and work throughout the value chain are in focus, with the goal of jointly contributing to reduced climate impact and long-term sustainable healthcare in Sweden.

Would your organization like to participate in the initiative?  Contact us here. 

Josefina Sallén

Expert cirkulära affärsmodeller
+46 72 208 93 60 Read more about Josefina
Profile image

Contact Josefina

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.

Ulrika Vejbrink

Innovations- och processledare
+46 10 228 44 38 Read more about Ulrika
Profile image

Contact Ulrika

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
AstraZeneca Region Stockholm Novo Nordisk Sveriges Apoteksförening Mölnlycke Health Care Swedish Medtech Wellspect Sweden Bio Apotea Apotek Hjärtat Västra Götalandsregionen Tamro Kronans Apotek Apoteket AB Doz Apotek RISE Läkemedelsverket Life Sciencekontoret Region Skåne Lif Bristol Myers Squibb Vanguard Läkare för miljön Chiesi
Information and Q&A for potential participants
Attach document: Project end date: Circular transition Sekundär områdes navigation:
Health and life science
Circular transition
System innovation